Dr. Martens Boots Recalled Over Chemical Hazard

More than 30,000 Dr. Martens Vegan boots have been recalled due to a risk of problems that may be caused by prolonged exposure to a chemical on the tongue lining, which may cause allergic reactions or other injuries.ย 

The Dr. Martens boots recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on August 24, indicating that consumers may experience problems following prolonged and direct contact with the chemical benzidine inside the boot lining.

Exposure to the chemical benzidine may cause skin allergies or rashes that may swell, blister and become irritated, cause discomfort.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

The recall includes about 30,900 Dr. Martens unisex Vegan 1460 eight eye boots, which are marked with the product code 14585 printed on the tongue label. The boots are black cherry in color and have black shoe laces with a thick sole and a golden heel pull tab marked with the manufacturer name, โ€œAirWairโ€. All sizes are included in the recall and the shoes are marked with batch code starting with โ€œGVโ€ and end with either Q, R, or S.

According to the CPSC, an estimated 30,000 pairs of the recalled boots were distributed for sale throughout the United States, and an additional 900 were distributed for sale in Canada.

The recalled Dr. Martens boots were manufactured in Vietnam under Airwair of Portland, Oregon. They were sold at Dr. Martens, Journeys and independent retail stores nationwide as well as online at Amazon.com, Dr.Martens.com, Shoebuy.com, and other online retailers from January 2015 through July 2017 for about $125.

The CPSC is encouraging all customers to stop wearing the boots immediately and to contact Dr. Martens for a full refund or free replacement product by contacting the manufacturers customer service department at 800-460-3930 or emailing them at dmservice@drmartens.com. Customers may also visit the companyโ€™s website at www.drmartens.com and navigate to the โ€œProduct Recallโ€ link for additional information.

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Both Abbott Laboratories and Boston Scientific are fighting against a call by plaintiffs to consolidate all spinal cord stimulator lawsuits before one federal judge for pretrial proceedings.
More than 4,000 women across the U.S. have filed product liability lawsuits and medical monitoring class action claims seeking compensation for potential brain tumor symptoms and side effects allegedly caused by Depo-Provera.
Plaintiffs in Uber driver sexual assault lawsuits have asked a federal judge to approve a Common Benefit Funds motion, which is usually a sign of some form of settlement agreement.